Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1975-09-09
1977-08-16
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
260112R, 260113, 260115, 424 88, 424287, A61K 3702, A61K 3714, C07G 704
Patent
active
040426890
ABSTRACT:
N-alkylated orgotein, like the native protein, possesses superoxide dismutase and anti-inflammatory activity.
REFERENCES:
patent: 3687927 (1972-08-01), Huber
patent: 3758682 (1973-09-01), Huber
Stansell, J. Biol. Chem., vol. 240, 1965, pp. 4306-4311.
Hartz, J. Biol. Chem, vol. 244, 1969, pp. 4565-4572.
Carrico, J. Biol. Chem, vol. 244, 1969, pp. 6087-6093.
Cole, J. Biol. Chem, vol. 233, 1958, pp. 1359-1363.
Neurath, The Proteins, Acad. Press, vol. I, 2nd Ed., 1963, pp. 14, 15, 383, 406-412.
Huber Wolfgang
Saifer Mark G.
Williams Lewis D.
Diagnostic Data, Inc.
Fagelson A. P.
Meyers Albert T.
LandOfFree
Alkylated orgotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylated orgotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylated orgotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-361671